thiscart19
Cell therapyexperimental
Clinical trial activity
13 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
13
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 7, 2020 (NCT04384393)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
- Anemia, Hemolytic, Autoimmune · Phase 1
- Automobiles · Phase 1
- Drug Therapy · Phase 1
- Immunotherapy, Adoptive · Phase 1
- Leukemia, B-Cell · Phase 1
- Leukemia, Lymphocytic, Chronic, B-Cell · Phase 1
- Leukemia, Lymphoid · Phase 1
- Lymphoma · Phase 1/Phase 2
- Lymphoma, B-Cell · Phase 1
- Lymphoma, Non-Hodgkin · Phase 1
- Neoplasms · Phase 1
- Precursor Cell Lymphoblastic Leukemia-Lymphoma · Early Phase 1
Mechanism of action
- B-lymphocyte antigen CD19Immunity, passive
CD19 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06212154 | Phase 1 | Jan 20, 2024 | China Academy of Chinese Medical Sciences |
| NCT07074496 | Early Phase 1 (Phase 1) | Jan 1, 2024 | Fundamenta Therapeutics, Ltd., Soochow University |
| NCT05776407 | Phase 1/Phase 2 (Phase 2) | May 31, 2023 | Chongqing Medical University, Fundamenta Therapeutics, Ltd. |
| NCT05691153 | Phase 1 | Dec 1, 2022 | Fundamenta Therapeutics, Ltd., Soochow University |
| NCT05640713 | Phase 1 | Dec 1, 2022 | Fundamenta Therapeutics, Ltd., Henan Medical University |
| NCT05576181 | Phase 1 | Oct 15, 2022 | Fundamenta Therapeutics, Ltd., Zhengzhou University |
| NCT05535673 | Phase 1 | Sep 2, 2022 | Fundamenta Therapeutics, Ltd., Zhengzhou University |
| NCT05350787 | Phase 1 | Mar 18, 2022 | Zhejiang University |
| NCT05349266 | Phase 1 | Mar 18, 2022 | Zhejiang University |
| NCT05350852 | Phase 1 | Mar 18, 2022 | Zhejiang University |
| NCT05340829 | Phase 1 | Mar 18, 2022 | Zhejiang University |
| NCT05106907 | Phase 1 | Oct 25, 2021 | Fundamenta Therapeutics, Ltd., Xuzhou Medical University |
| NCT04384393 | Phase 1 | May 7, 2020 | Anhui Medical University, Fundamenta Therapeutics, Ltd. |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fundamenta Therapeutics, Ltd. | For profit | 8 | 3 | 2 | 2020 |
| Zhejiang University | Academic/Hospital | 4 | 4 | 1 | 2022 |
| Soochow University | Academic/Hospital | 2 | 2 | 1 | 2022 |
| Zhengzhou University | Academic/Hospital | 2 | 1 | 1 | 2022 |
| Anhui Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| China Academy of Chinese Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Chongqing Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Henan Medical University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Xuzhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2021 |
9 organizations
Page 1 / 1